Here we compare the published data from the STEP-1, SURMOUNT-1, and TRIUMPH-4 trials without marketing spin: -14,9% for semaglutide, -20,9% for the tirzepatide-28,7% for the retatrutideThe retatrutide vs tirzepatide vs semaglutide comparison also incorporates tolerance (dysesthesia 20,9% at the 12 mg dose level of retatrutide), pleiotropic effects 2024-2025 (apnea, heart failure, MASLD), and the updated regulatory status in France 2026
The result is still the same: an increased risk for cardiovascular problems
Usage Period : Less than 1 week Purchase Point :
But theres a hidden layer many outside the pharmacy world dont talk about: Prior authorizations and insurance delays still create barriers even for generics
Many talks exist surrounding B12 injection, one of which is that Vitamin B12 injections can affect your weight and cause inflammation
Semaglutide is a medication primarily used for managing type 2 diabetes and chronic weight management